Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Malaria
Interventions
DRUG

Primaquine

A single low dose of primaquine will be crushed and dissolved in water, and administered in weight-based doses.

Trial Locations (1)

Unknown

Malaria Research and Training Centre, Bamako

All Listed Sponsors
collaborator

Malaria Research and Training Center, Bamako, Mali

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

University of Mississippi Medical Center

OTHER

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

University of California, San Francisco

OTHER

NCT02535767 - Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali | Biotech Hunter | Biotech Hunter